145 related articles for article (PubMed ID: 21595853)
1. Parathyroid hormone control survey to determine inter-method and inter-lab variations in Japan.
Kakuta T; Kato H; Komaba H; Akizawa T;
Ther Apher Dial; 2011 Jun; 15 Suppl 1():50-5. PubMed ID: 21595853
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Higher parathyroid hormone (PTH) concentrations with the Architect PTH assay than with the Elecsys assay in hemodialysis patients, and a simple way to standardize these two methods.
Monge M; Jean G; Bacri JL; Lemaitre V; Masy E; Joly D; Souberbielle JC
Clin Chem Lab Med; 2009; 47(3):362-6. PubMed ID: 19199835
[TBL] [Abstract][Full Text] [Related]
4. Immunoassays for the detection of parathyroid hormone.
Jüppner H; Potts JT
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N81-6. PubMed ID: 12412782
[TBL] [Abstract][Full Text] [Related]
5. Major method-specific differences in the measurement of intact parathyroid hormone: studies in patients with and without chronic renal failure.
Worth GK; Vasikaran SD; Retallack RW; Musk AA; Gutteridge DH
Ann Clin Biochem; 2004 Mar; 41(Pt 2):149-54. PubMed ID: 15025807
[TBL] [Abstract][Full Text] [Related]
6. High serum levels of a non-(1-84) parathyroid hormone (PTH) fragment in pediatric haemodialysis patients.
Salomon R; Charbit M; Gagnadoux MF; Niaudet P; Gao P; Cantor T; Souberbielle JC
Pediatr Nephrol; 2001 Dec; 16(12):1011-4. PubMed ID: 11793090
[TBL] [Abstract][Full Text] [Related]
7. Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values.
Cavalier E; Delanaye P; Vranken L; Bekaert AC; Carlisi A; Chapelle JP; Souberbielle JC
Nephrol Dial Transplant; 2012 May; 27(5):1950-6. PubMed ID: 21940481
[TBL] [Abstract][Full Text] [Related]
8. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010.
Hermsen D; Franzson L; Hoffmann JP; Isaksson A; Kaufman JM; Leary E; Müller C; Nakatsuka K; Nishizawa Y; Reinauer H; Riesen W; Roth HJ; Steinmüller T; Troch T; Bergmann P
Clin Lab; 2002; 48(3-4):131-41. PubMed ID: 11934215
[TBL] [Abstract][Full Text] [Related]
9. CAP survey of parathyroid hormone assays.
Klee GG; Shikegawa J; Trainer TD
Arch Pathol Lab Med; 1986 Jul; 110(7):588-91. PubMed ID: 3755023
[TBL] [Abstract][Full Text] [Related]
10. [Intact whole bioactive parathormone: problems arising from comparing different methods].
Marangella M; Migliardi M; Dutto F; Mengozzi G; Marranca D; Bagnis C; Berutti S; Gallone G; Aimo G; Ramello A; Fonzo D
G Ital Nefrol; 2002; 19(4):467-75. PubMed ID: 12369051
[TBL] [Abstract][Full Text] [Related]
11. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism.
Kaczirek K; Prager G; Riss P; Wunderer G; Asari R; Scheuba C; Bieglmayer C; Niederle B
Arch Surg; 2006 Feb; 141(2):129-34; discussion 134. PubMed ID: 16490888
[TBL] [Abstract][Full Text] [Related]
12. [PTH measurement: where do we stand?].
Marangella M
G Ital Nefrol; 2009; 26(5):600-7. PubMed ID: 19802805
[TBL] [Abstract][Full Text] [Related]
13. Inter-method variability in PTH measurement: implication for the care of CKD patients.
Souberbielle JC; Boutten A; Carlier MC; Chevenne D; Coumaros G; Lawson-Body E; Massart C; Monge M; Myara J; Parent X; Plouvier E; Houillier P
Kidney Int; 2006 Jul; 70(2):345-50. PubMed ID: 16788691
[TBL] [Abstract][Full Text] [Related]
14. Comparison between whole and intact parathyroid hormone assays.
Taniguchi M; Tanaka M; Hamano T; Nakanishi S; Fujii H; Kato H; Koiwa F; Ando R; Kimata N; Akiba T; Kono T; Yokoyama K; Shigematsu T; Kakuta T; Kazama JJ; Tominaga Y; Fukagawa M
Ther Apher Dial; 2011 Jun; 15 Suppl 1():42-9. PubMed ID: 21595852
[TBL] [Abstract][Full Text] [Related]
15. Quantification of recombinant human parathyroid hormone (rhPTH(1-84)) in human plasma by immunoassay: commercial kit evaluation and validation to support pharmacokinetic studies.
Sukovaty RL; Lee JW; Fox J; Toney K; Papac DI; Grover TA; Wells DS
J Pharm Biomed Anal; 2006 Sep; 42(2):261-71. PubMed ID: 16765549
[TBL] [Abstract][Full Text] [Related]
16. Measurement of parathyroid hormone.
Endres DB; Villanueva R; Sharp CF; Singer FR
Endocrinol Metab Clin North Am; 1989 Sep; 18(3):611-29. PubMed ID: 2673765
[TBL] [Abstract][Full Text] [Related]
17. Overproduction and secretion of a novel amino-terminal form of parathyroid hormone from a severe type of parathyroid hyperplasia in uremia.
Arakawa T; D'Amour P; Rousseau L; Brossard JH; Sakai M; Kasumoto H; Igaki N; Goto T; Cantor T; Fukagawa M
Clin J Am Soc Nephrol; 2006 May; 1(3):525-31. PubMed ID: 17699255
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two parathyroid hormone assays for the rat: the new immunoradiometric and the older competitive binding assay.
Jara A; Bover J; Lavigne J; Felsenfeld A
J Bone Miner Res; 1994 Oct; 9(10):1629-33. PubMed ID: 7817810
[TBL] [Abstract][Full Text] [Related]
19. Bio-intact parathyroid hormone and intact parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism receiving intravenous calcitriol therapy.
Fujimori A; Sakai M; Yoshiya K; Shin J; Kim JI; Inaba Y; Miyamoto T; Inoue S; Fukagawa M
Ther Apher Dial; 2004 Dec; 8(6):474-9. PubMed ID: 15663547
[TBL] [Abstract][Full Text] [Related]
20. Comparison of three different immunoassay methods for the evaluation of intact parathyroid hormone levels in hemodialysis patients.
Ates F; Koken T; Demir S; Kahraman A; Dogan N
Scand J Clin Lab Invest; 2011 May; 71(3):227-31. PubMed ID: 21294669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
